Conference Abstract

Utilization, user characteristics, and adverse outcomes of insulin glargine originators and follow-on drug in patients with diabetes in the US

August 1, 2022
Authors:

Rai A, Nam YH, Mendelsohn AB, Marshall J, McDermott CL, Toh S, Lockhart CM

Expertise:
RWE Research & Consulting
Home
Publications
Utilization, user characteristics, and adverse outcomes of insulin glargine originators and follow-on drug in patients with diabetes in the US
...

Poster presented at the 38th Annual International Society for Pharmacoepidemiology Conference

View the Poster
CONTACT US

© Real-World Evidence Practice. All rights reserved.

Harvard Pilgrim Health Care Institute Department of Population Medicine
Privacy Policy